Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 19CNS 1

Conditions

Glioblastoma 80Brain Neoplasms 34Gliosarcoma 30Glioma 24Astrocytoma 18Central Nervous System Neoplasms 11Medulloblastoma 9Oligodendroglioma 5Neuroblastoma 5Ganglioneuroblastoma 5Ependymoma 4Diffuse Intrinsic Pontine Glioma 4Neoplasms 3Breast Neoplasms 3Meningeal Carcinomatosis 2Melanoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Untreated Childhood Anaplastic Astrocytoma 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Recurrence 1Rare Diseases 1Prostatic Neoplasms 1Pinealoma 1

Interventions

regorafenib 2Nivolumab 2pembrolizumab 1aflibercept 1adavosertib 1Radiotherapy 1Radiation 1Paclitaxel 1NEO212 1Ipilimumab 1IFL protocol 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Radiation × CNS × Clear all
NCT04460937 2026-04-29

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

National Cancer Institute (NCI)

Phase 1 Active not recruiting
4 enrolled 9 charts
CNSGastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Brain Neoplasms, Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡